October 13, 2022: Replay of Microbiome session of the 2022 edition of HTID with Hervé Affagard

2022 edition of HealthTech Innovation Days: replay of “Translational microbiome medicine to treat serious oncology and infectious diseases”.

During one hour, industry leaders including our CEO Hervé Affagard and world-renowned specialists discussed how the gut #microbiota is becoming a cornerstone in treating serious diseases and cancer.

To access the replay, click here!

Previous PostNovember 3, 2022: MaaT Pharma Announces Oral and Poster Presentations at the 64th American Society of Hematology (ASH) Annual Meeting
Next PostOctober 12, 2022: Interview of Hervé Affagard in Lyon Décideurs - Bourses & Valeurs

MaaT Pharma dans les médias MaaT Pharma in the News Devenez membre du club Become a member of the club

October 13, 2022: Replay of Microbiome session of the 2022 edition of HTID with Hervé Affagard

Date : 13/10/2022

Previous PostNovember 3, 2022: MaaT Pharma Announces Oral and Poster Presentations at the 64th American Society of Hematology (ASH) Annual Meeting

Next PostOctober 12, 2022: Interview of Hervé Affagard in Lyon Décideurs - Bourses & Valeurs

COMPANY

Ressources

Contact